Thakur, P., Lackinger, M., Diamantopoulou, A., Rao, S., Chen, Y., Khalizova, K., Ferng, A., Mazur, C., Kordasiewicz, H., Shprintzen, R. J., Markx, S., Xu, B., & Gogos, J. A. (2025). An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome. ELife, 13. CLOCKSS. https://doi.org/10.7554/elife.103328

Lendemeijer, B., & de Vrij, F. M. S. (2025). In vitro models for human neuroglia. Neuroglia in the Healthy Nervous System, Part I, 213–227. https://doi.org/10.1016/b978-0-443-19104-6.00015-2

Kowanda, M., Smith, R. S., Lundy, J., Kentros, C., Kleinman, E., Walsh, L. K., Schratt, G., Taylor, C., & Chung, W. (2024). P612: Improvement of variant reclassification in genetic neurodevelopmental conditions: Simons Searchlight research registry. Genetics in Medicine Open, 2, 101518. https://doi.org/10.1016/j.gimo.2024.101518

Kowanda, M., Calakos, K., Snyder, L. G., Kentros, C., Bain, J., Srivastava, S., Sands, T., Schratt, G., Taylor, C., & Chung, W. (2024). P152: Seizure severity across neurogenetic conditions in Simons Searchlight*. Genetics in Medicine Open, 2, 101049. https://doi.org/10.1016/j.gimo.2024.101049

Li, Y., Sun, Z., Zhu, H., Sun, Y., Shteyman, D. B., Markx, S., Leong, K. W., Xu, B., & Fu, B. M. (2023). Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood–Brain Barriers. Cells, 12(3), 422. https://doi.org/10.3390/cells12030422

Fenster, R., Ziegler, A., Kentros, C., Geltzeiler, A., Green Snyder, L., Brooks, E., & Chung, W. K. (2022). Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures. American Journal of Medical Genetics Part A, 188(7), 1954–1963. Portico. https://doi.org/10.1002/ajmg.a.62721

Kahen, A., Kavus, H., Geltzeiler, A., Kentros, C., Taylor, C., Brooks, E., Green Snyder, L., & Chung, W. (2021). Neurodevelopmental phenotypes associated with pathogenic variants in SLC6A1. Journal of Medical Genetics, 59(6), 536–543. https://doi.org/10.1136/jmedgenet-2021-107694

de Jong, J. O., Llapashtica, C., Genestine, M., Strauss, K., Provenzano, F., Sun, Y., Zhu, H., Cortese, G. P., Brundu, F., Brigatti, K. W., Corneo, B., Migliori, B., Tomer, R., Kushner, S. A., Kellendonk, C., Javitch, J. A., Xu, B., & Markx, S. (2021). Cortical overgrowth in a preclinical forebrain organoid model of CNTNAP2-associated autism spectrum disorder. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-24358-4

Li, Y., Xia, Y., Zhu, H., Luu, E., Huang, G., Sun, Y., Sun, K., Markx, S., Leong, K. W., Xu, B., & Fu, B. M. (2021). Investigation of Neurodevelopmental Deficits of 22 q11.2 Deletion Syndrome with a Patient-iPSC-Derived Blood–Brain Barrier Model. Cells, 10(10), 2576. https://doi.org/10.3390/cells10102576

Kowanda, M., Cartner, L., Kentros, C., Geltzeiler, A. R., Singer, K. E., Weaver, W. C., Lehman, C. D., Smith, S., Smith, R. S., Walsh, L. K., Diehl, K., Nagpal, N., Brooks, E., Mebane, C. M., Wilson, A. L., Marvin, A. R., White, L. C., Law, J. K., Jensen, W., … Chung, W. K. (2021). Availability of Services and Caregiver Burden: Supporting Individuals With Neurogenetic Conditions During the COVID-19 Pandemic. Journal of Child Neurology, 36(9), 760–767. https://doi.org/10.1177/08830738211001209